Drug Shortage Report for LOVENOX

Last updated on 2022-01-14 History
Report ID 138194
Drug Identification Number 02378426
Brand name LOVENOX
Common or Proper name Lovenox
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) ENOXAPARIN SODIUM
Strength(s) 60MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 10
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-12-20
Actual start date
Estimated end date 2022-01-31
Actual end date 2022-01-13
Shortage status Resolved
Updated date 2022-01-14
Company comments Transportation delay and overselling is leading to a limited supply of product. Allocation will be kept in place to mitigate the anticipated shortage.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v27 2022-01-14 English Compare
v26 2022-01-13 French Compare
v25 2022-01-13 English Compare
v24 2022-01-06 French Compare
v23 2022-01-06 English Compare
v22 2021-12-21 English Compare
v21 2021-11-10 French Compare
v20 2021-11-10 English Compare
v19 2021-11-03 English Compare
v18 2021-09-30 French Compare
v17 2021-09-30 English Compare
v16 2021-07-13 French Compare
v15 2021-07-13 English Compare
v14 2021-06-16 French Compare
v13 2021-06-16 English Compare
v12 2021-06-08 French Compare
v11 2021-06-08 English Compare
v10 2021-05-18 French Compare
v9 2021-05-18 English Compare
v8 2021-05-17 French Compare

Showing 1 to 20 of 27